LMR Partners’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$332K Buy
+5,900
New +$266K ﹤0.01% 1280
2025
Q1
– Sell
-16,313
Closed -$499K – 1371
2024
Q4
$499K Buy
+16,313
New +$525K ﹤0.01% 838
2014
Q2
– Sell
-21,056
Closed -$396K – 465
2014
Q1
$396K Buy
+21,056
New +$431K 0.06% 156

Other funds holding ATRC

LMR Partners's ATRC Position: Q3 2026 in Review

LMR Partners opened a new position in AtriCure (ATRC) in Q3 2026: 5,900 shares worth $332K. The stake represents ﹤0.01% of the portfolio and ranks #1280 among its holdings. This is a return to the name: LMR Partners previously reported a position in ATRC as recently as Q4 2024.

LMR Partners first reported a position in ATRC in Q1 2014 and has held it in 3 quarters since. The position peaked at $499K in Q4 2024. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • LMR Partners held 5,900 shares of AtriCure worth $332K as of Q3 2026.
  • AtriCure was a new LMR Partners position in Q3 2026.
  • AtriCure made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1280 holding.
  • LMR Partners first reported a position in AtriCure in Q1 2014 and has held it in 3 quarters since.
  • LMR Partners's AtriCure position peaked at $499K in Q4 2024.
  • 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.